News & Media



Defence Therapeutics: Our Vaccine Treatment


Defence Therapeutics announces 2 clinical trials for 2023

Developing Next Generation Biopharmaceutical Innovations

Making a Global Impact

Defence Therapeutics Family Office Presentation – London UK

Defence Therapeutics spotlight on BTV

News Releases

Defence Completes 2nd Tranche of Financing

Defence Completes 2nd Tranche of Financing

Vancouver, BC, Canada, March 22nd, 2024 - Defence Therapeutics Inc. (“Defence” or the “Company”), (CSE: DTC, OTCQB: DTCFF, FSE: DTC), one of the leading Canadian biotechnology companies working in the field of immune-oncology, announces the closing of the 2nd tranche...

read more